Latest MS research news

Latest MS research news | 26 November 2013

Cortical plasticity predicts recovery from relapse in multiple sclerosis

This study showed that increased long term potentiation measured at the time of relapse was associated with an improved clinical recovery after a relapse, which may represent an important player for recovery.

From MSIF

Latest MS research news | 26 November 2013

Disclosure of diagnosis of multiple sclerosis in the workplace positively affects employment status and job tenure

This interesting study looked at the importance of disclosure of diagnosis of MS in the workplace and showed that disclosure to an employer increases job retention.

From MSIF

Latest MS research news | 26 November 2013

Using magnetic resonance imaging in animal models to guide drug development in multiple sclerosis

This review article looks at the importance of incorporating MRI into animal studies testing new potential treatments in MS.

From MSIF

Latest MS research news | 19 November 2013

Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population

The effects of starting fingolimod on the heart remain consistent with results from previous studies, even when patients with pre-existing cardiac conditions are included.

From MSIF

Latest MS research news | 19 November 2013

Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT

This extension study of the BENEFIT trial showed that patients who received early treatment had a lower risk of conversion to clinically definite MS, lower annualised relapse rate and longer time to recurrent relapses than those who received delayed treatment.

From MSIF

Latest MS research news | 19 November 2013

An RCT to treat learning impairment in multiple sclerosis: The MEMREHAB trial

This study showed that the treatment group showed significant improvements in learning compared with the placebo controlled group. They show that a targeted behavioural intervention can improve memory performance.

From MSIF

Latest MS research news | 13 November 2013

Risk genes associated with paediatric-onset MS but not with monophasic acquired CNS demyelination

Genetic loci associated with adult onset-MS is also associated with an increased risk to MS in children. This has the potential to predict MS diagnosis in children who present with a once off acquired demyelinating syndrome.

From MSIF

Latest MS research news | 13 November 2013

Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations.

This study showed that the number of cases of LHON-MS fell in a range that could be predicted by the chance occurrence of MS and the genetic mutations known to cause LHON.

From MSIF

Latest MS research news | 13 November 2013

Detecting cognitive dysfunction in a busy multiple sclerosis clinical setting: a computer generated approach

A computerised battery of memory tests was used to detect memory problems in subjects with different types of MS. It can be successfully administered in 20 minutes and may have a potential role in a busy clinic setting.

From MSIF

Latest MS research news | 05 November 2013

Clinically meaningful performance benchmarks in MS: timed 25-foot walk and the real world

The Timed-25 Foot Walk (T25FW) measures walking function in MS. This study found a performance of ≥6 seconds and ≥8 seconds represents clinically meaningful benchmarks of MS progression.

From MSIF
 

Latest MS research news

Main MS research areas

Challenges of MS research

Atacicept in multiple sclerosis: a randomised, placebo-controlled, double-blind, phase 2 trial